PetVivo to sponsor canine joint injection lab at Southwest Veterinary Symposium

PetVivo Holdings will exhibit Spryng with OsteoCushion Technology and sponsor a sold-out canine joint injection lab at the 2026 Southwest Veterinary Symposium in San Antonio. The move puts the company in front of veterinarians focused on osteoarthritis and joint-care treatment options.

Why it matters: - PetVivo is using a major veterinary conference to showcase Spryng with OsteoCushion Technology to veterinarians treating joint-related conditions in companion animals and horses. - Sponsoring a hands-on injection lab gives PetVivo direct exposure to clinicians who influence treatment choices for canine osteoarthritis. - The conference setting supports awareness for a commercial product already available for sale.

What happened: - PetVivo Animal Health, with its parent PetVivo Holdings and subsidiaries Somatrix Technologies and PetVivo AI, said it will exhibit at the 2026 Southwest Veterinary Symposium in San Antonio. - The symposium runs Sept. 17-20, 2026, at the Henry B. González Convention Center. - PetVivo will show Spryng with OsteoCushion Technology at Booth 727. - PetVivo is also sponsoring the symposium’s Canine Joint Injection Lab.

The details: - The sponsored lab is scheduled for Friday, Sept. 18, 2026, from 8 a.m. to 12 p.m. - The lab is a sold-out interactive program built around hands-on practice in canine joint-injection techniques. - PetVivo said the lab aligns with its focus on tools for managing osteoarthritis and other joint-related conditions. - Spryng is an intra-articular injectable veterinary medical device made of sterilized extracellular matrix microparticles. - The microparticles are designed to work with synovial fluid to mimic the form and function of natural joint cartilage and help restore joint mechanics. - Spryng is intended for horses and companion animals to aid in managing lameness, joint pain and osteoarthritis tied to joint dysfunction not caused by infection. - Conference exhibit hours are Thursday, Sept. 17, from 1 p.m. to 4 p.m.; Friday, Sept. 18, from 9:30 a.m. to 5 p.m.; and Saturday, Sept. 19, from 9:30 a.m. to 4:30 p.m. - More information is available through PetVivo's website, PetVivo Animal Health and Spryng Health.

Between the lines: - The symposium sponsorship doubles as marketing and education, letting PetVivo pair product visibility with practical training for veterinarians. - CEO John Lai said the event offers an opportunity to engage directly with veterinarians focused on osteoarthritis and other joint-related conditions. - Lai said the educational program fits PetVivo’s commitment to supporting veterinarians with innovative solutions for lameness, joint pain and osteoarthritis.

What's next: - PetVivo will appear at the symposium in mid-September and use the event to promote Spryng to veterinary attendees. - The company is also positioning the product for continued commercial use in cats, dogs and horses.

The bottom line: - PetVivo is leaning on veterinary education and conference visibility to expand awareness of Spryng among animal-health practitioners.